Insider Selling: Omada Health (NASDAQ:OMDA) President Sells $88,186.60 in Stock

Key Points

• Omada Health President Wei-Li Shao sold 4,036 shares at an average price of $21.85, totaling $88,186.60. After the transaction, Shao retained 295,313 shares valued at approximately $6.45 million.
• Omada shares recently traded at $20.50, with a market capitalization of about $1.26 billion and a 52-week range of $10.28 to $26.92. The company’s latest quarterly results beat expectations, reporting $0.08 in EPS and $87.83 million in revenue.
• Analyst sentiment remains positive, with an overall “Moderate Buy” rating and a consensus price target of $26.67, while several institutional investors recently initiated or increased positions in the stock.

Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) President Wei-Li Shao sold 4,036 shares of the business's stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $21.85, for a total value of $88,186.60. Following the sale, the president directly owned 295,313 shares of the company's stock, valued at $6,452,589.05. This represents a 1.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Wei-Li Shao also recently made the following trade(s):

• On Wednesday, August 12th, Wei-Li Shao sold 8,866 shares of Omada Health stock. The stock was sold at an average price of $25.02, for a total transaction of $221,827.32.

Omada Health Price Performance

Shares of NASDAQ OMDA traded up $0.84 during mid-day trading on Monday, reaching $20.50. 961,447 shares of the company's stock were exchanged, compared to its average volume of 1,250,359. The firm has a market capitalization of $1.26 billion, a price-to-earnings ratio of 410.00 and a beta of 1.86. The firm has a 50-day moving average price of $22.63 and a two-hundred day moving average price of $17.97. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92.

Omada Health (NASDAQ:OMDA - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.10. The business had revenue of $87.83 million during the quarter, compared to analyst estimates of $80.93 million. Omada Health had a return on equity of 2.60% and a net margin of 1.39%. As a group, sell-side analysts forecast that Omada Health, Inc. will post 0.09 EPS for the current fiscal year.

Analysts Set New Price Targets

OMDA has been the subject of several research reports. Morgan Stanley reaffirmed an "overweight" rating and issued a $30.00 target price on shares of Omada Health in a research note on Monday, June 22nd. BTIG Research restated a "buy" rating and issued a $35.00 price target on shares of Omada Health in a research note on Friday. Wall Street Zen raised Omada Health from a "hold" rating to a "buy" rating in a research report on Saturday, August 8th. Citigroup reiterated an "outperform" rating on shares of Omada Health in a research note on Friday, August 14th. Finally, Robert W. Baird increased their target price on Omada Health from $15.00 to $25.00 and gave the company a "neutral" rating in a report on Wednesday, August 12th. Eleven analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $26.67.

Institutional Investors Weigh In On Omada Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OMDA. WINTON GROUP Ltd purchased a new stake in Omada Health during the second quarter worth $1,101,000. Integrated Wealth Concepts LLC purchased a new position in shares of Omada Health during the second quarter worth $53,000. Squarepoint Ops LLC acquired a new position in shares of Omada Health in the 2nd quarter valued at about $2,044,000. Corient Private Wealth LP boosted its position in Omada Health by 252.5% in the 2nd quarter. Corient Private Wealth LP now owns 145,118 shares of the company's stock worth $3,185,000 after purchasing an additional 103,955 shares in the last quarter. Finally, California State Teachers Retirement System raised its position in shares of Omada Health by 465.1% in the second quarter. California State Teachers Retirement System now owns 10,229 shares of the company's stock worth $225,000 after acquiring an additional 8,419 shares during the period.

Omada Health Company Profile

Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.

The company's offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada's programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.

Omada primarily serves members through employers, health plans and healthcare organizations in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.